BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 18590843)

  • 21. Pseudomyxoma peritonei: a clinicopathologic analysis and follow-up of 21 patients.
    Varona JF; Guerra JM; Salamanca J; Colina F; Lopez G; Morales M
    Hepatogastroenterology; 2005; 52(63):812-6. PubMed ID: 15966210
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pseudomyxoma peritonei: the 'controversial' disease.
    Galani E; Marx GM; Steer CB; Culora G; Harper PG
    Int J Gynecol Cancer; 2003; 13(4):413-8. PubMed ID: 12911716
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intraperitoneal hyperthermia in the management of pseudomyxoma peritonei.
    Hsu KH; Chou CY; Chang YC
    Hepatogastroenterology; 2007; 54(73):47-52. PubMed ID: 17419229
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Peritoneal pseudomyxoma: an overview emphasizing pathological assessment and therapeutic strategies].
    Dartigues P; Isaac S; Villeneuve L; Glehen O; Capovilla M; Chevallier A; Croce S; Kaci R; Lang-Averous G; Laverriere MH; Leroux-Broussier A; Mery É; Poizat F; Valmary-Degano S; Verriele-Beurrier V; Gilly FN; Bibeau F
    Ann Pathol; 2014 Feb; 34(1):14-25. PubMed ID: 24630633
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Peritoneal carcinosis can have as good a prognosis as primary colonic cancer, and should be managed according to evidence-based practice].
    Graf W; Mahteme H
    Lakartidningen; 2010 May 12-25; 107(19-20):1320. PubMed ID: 20556987
    [No Abstract]   [Full Text] [Related]  

  • 26. A case of pseudomyxoma peritonei with a unique palliative therapy.
    Tahseen S; McLean G
    J Obstet Gynaecol; 2003 Nov; 23(6):679-80. PubMed ID: 14617486
    [No Abstract]   [Full Text] [Related]  

  • 27. [Prognostic difficulties in pseudomyxoma peritonei].
    Arendt J; Sieroń A; Biniszkiewicz T; Jagodziński L; Waniczek D
    Wiad Lek; 2003; 56(1-2):71-5. PubMed ID: 12901272
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A case of pseudomyxoma peritonei successfully treated with intra-peritoneal hyperthermia].
    Okugawa T; Yamada K; Futamura N; Ida M; Nishimura K; Nose Y; Uematsu A; Toyoda N
    Nihon Sanka Fujinka Gakkai Zasshi; 1993 Nov; 45(11):1345-8. PubMed ID: 8258736
    [No Abstract]   [Full Text] [Related]  

  • 29. [Extensive peritonectomy. A new treatment approach to pseudomyxoma peritonei].
    Iversen LH; Rasmussen PC; Wara P; Buhl L; Ambrose NS; Laurberg S
    Ugeskr Laeger; 2004 Aug; 166(35):2981-4. PubMed ID: 15387007
    [No Abstract]   [Full Text] [Related]  

  • 30. Pseudomyxoma peritonei. Histologic predictors of patient survival.
    Costa MJ
    Arch Pathol Lab Med; 1994 Dec; 118(12):1215-9. PubMed ID: 7979917
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Laparoscopic approach in complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy by CO
    Arjona-Sánchez Á; Rodríguez-Ortiz L; Rufián-Peña S; Sánchez-Hidalgo JM; Briceño-Delgado J
    Cir Esp (Engl Ed); 2018 Dec; 96(10):656-658. PubMed ID: 29937297
    [No Abstract]   [Full Text] [Related]  

  • 32. Malignant melanoma.
    Califano J; Nance M
    Facial Plast Surg Clin North Am; 2009 Aug; 17(3):337-48. PubMed ID: 19698915
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of therapy in the treatment of pseudomyxoma peritonei.
    Miner TJ
    Cancer Treat Res; 2007; 134():329-42. PubMed ID: 17633064
    [No Abstract]   [Full Text] [Related]  

  • 34. Management of pseudomyxoma peritonei.
    Fallis SA; Moran BJ
    J BUON; 2015 May; 20 Suppl 1():S47-55. PubMed ID: 26051332
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Progression of pseudomyxoma peritonei after combined modality treatment: management and outcome.
    Smeenk RM; Verwaal VJ; Antonini N; Zoetmulder FA
    Ann Surg Oncol; 2007 Feb; 14(2):493-9. PubMed ID: 17103067
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early results of surgery in 123 patients with pseudomyxoma peritonei from a perforated appendiceal neoplasm.
    Murphy EM; Sexton R; Moran BJ
    Dis Colon Rectum; 2007 Jan; 50(1):37-42. PubMed ID: 17115339
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low-grade mucinous epithelial neoplasm (intestinal type) arising in a mature sacrococcygeal teratoma with late recurrence as pseudomyxoma peritonei.
    McKenney JK; Longacre TA
    Hum Pathol; 2008 Apr; 39(4):629-32. PubMed ID: 18289636
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Short-term outcomes following cytoreductive surgery and heated intra-peritoneal chemotherapy at Waikato.
    Ly NJ; Wu L; Dalen RV; Lolohea S
    N Z Med J; 2017 Jul; 130(1459):33-42. PubMed ID: 28727692
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Consensus statement on the loco-regional treatment of appendiceal mucinous neoplasms with peritoneal dissemination (pseudomyxoma peritonei).
    Moran B; Baratti D; Yan TD; Kusamura S; Deraco M
    J Surg Oncol; 2008 Sep; 98(4):277-82. PubMed ID: 18726894
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elevated tumour markers prior to complete tumour removal in patients with pseudomyxoma peritonei predict early recurrence.
    Alexander-Sefre F; Chandrakumaran K; Banerjee S; Sexton R; Thomas JM; Moran B
    Colorectal Dis; 2005 Jul; 7(4):382-6. PubMed ID: 15932563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.